
HZ Risk With Psoriasis Biologics, Traditional Rxs Compared
TOPLINE: Patients with moderate to severe psoriasis treated with ustekinumab and guselkumab showed a trend towards a lower risk for herpes zoster (HZ) and postherpetic neuralgia (PHN) than those receiving traditional systemic treatments. Adalimumab was …